BBHC
ADPT icon

Brown Brothers Harriman & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$1K – 1253
2022
Q3 		$1K Buy
+200
New +$1.88K ﹤0.01% 1452

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Brothers Harriman & Co's ADPT Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Adaptive Biotechnologies (ADPT) in Q4 2022, closing a stake of 200 shares — an estimated $1K sold.

Brown Brothers Harriman & Co first reported a position in ADPT in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 223 funds tracked by Wall St. Rank hold ADPT as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Adaptive Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 200 Adaptive Biotechnologies shares in Q4 2022, an estimated $1K.
  • Brown Brothers Harriman & Co first reported a position in Adaptive Biotechnologies in Q3 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Adaptive Biotechnologies position peaked at $1K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.